Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016

Affiliations

• ¹ Department of Neuro‑Oncology, University and City of Health and Science Hospital, Via Cherasco 15, 10126, Turin, Italy. [email protected].
• ² Department of Neuro‑Oncology, University and City of Health and Science Hospital, Via Cherasco 15, 10126, Turin, Italy.
• ³ Department of Neurosurgery, I.R.C.C.S. Regina Elena National Cancer Institute, Rome, Italy.
• ⁴ Department of Medical Oncology, Regional Hospital, Bolzano, Italy.
• ⁵ Department of Neurosurgery, Regional Hospital, Milan, Italy.
• ⁶ Department of Medical Oncology, Regional Hospital, Cesena, Italy.
• ⁷ Department of Neurosurgery, University of Milan, Milan, Italy.
• ⁸ Unit of Cancer Epidemiology (CPO Piemonte), University of Turin, Turin, Italy.
• ⁹ Department of Biomedical Sciences, University and City of Health and Science Hospital, Turin, Italy.